Emergent BioSolutions Inc. — Director's Dealing 2014

Feb 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2013-11-12

Reporting Person: Labinger Barry (EVP, Biosciences Div.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-12	Common Stock	A	15142	—	Acquired	15412	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-12	Employee Stock Option (right to buy)	$20.94	A	30284	Acquired	2020-11-11	Common Stock (30284)	Direct

Footnotes

F1: These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement

F2: Vests in three equal installments on November 11, 2014, November 11, 2015 and November 11, 2016